Takeda surpasses analyst forecasts in Q1

Bloomberg reports that Takeda Pharmaceuticals surpassed analyst predictions in the first quarter of the year.

Lundbeck headquarters. | Photo: Lundbeck / PR

Takeda Pharmaceuticals, whose partner is Danish Lundbeck, surpassed analyst predictions in the first quarter, according to Bloomberg News.

In Q1, Takeda Pharmaceuticals had a revenue of JPY 949.60bn (USD 8.67bn).

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs